Share on StockTwits

athenahealth (NASDAQ:ATHN) Insider Stephen N. Kahane sold 10,000 shares of athenahealth stock in a transaction that occurred on Wednesday, April 16th. The shares were sold at an average price of $143.96, for a total value of $1,439,600.00. Following the completion of the sale, the insider now directly owns 69,285 shares in the company, valued at approximately $9,974,269. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.

athenahealth (NASDAQ:ATHN) traded down 1.55% during mid-day trading on Friday, hitting $145.58. 896,596 shares of the company’s stock traded hands. athenahealth has a one year low of $82.01 and a one year high of $206.70. The stock’s 50-day moving average is $169.2 and its 200-day moving average is $146.1. The company has a market cap of $5.442 billion and a P/E ratio of 2112.43.

athenahealth (NASDAQ:ATHN) last released its earnings data on Thursday, April 17th. The company reported $0.12 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.17 by $0.05. The company had revenue of $163.00 million for the quarter, compared to the consensus estimate of $170.03 million. During the same quarter in the previous year, the company posted $0.38 earnings per share. The company’s revenue for the quarter was up 29.8% on a year-over-year basis. Analysts expect that athenahealth will post $1.08 EPS for the current fiscal year.

ATHN has been the subject of a number of recent research reports. Analysts at Oppenheimer cut their price target on shares of athenahealth from $140.00 to $120.00 in a research note on Thursday. Separately, analysts at Raymond James reiterated a “market perform” rating on shares of athenahealth in a research note on Tuesday. Finally, analysts at SunTrust initiated coverage on shares of athenahealth in a research note on Tuesday, March 25th. They set a “neutral” rating and a $170.00 price target on the stock. Two investment analysts have rated the stock with a sell rating, twelve have given a hold rating and nine have given a buy rating to the company. The company presently has an average rating of “Hold” and an average target price of $163.06.

athenahealth, Inc (NASDAQ:ATHN), is a business services company, which provides ongoing billing, clinical-related, and other related services to its customers.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.